INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2011

A review of 62 studies proposed a carotenoid health index linking higher plasma carotenoids to lower risks of mortality, metabolic syndrome, and cancer.

Sixty-two studies of plasma carotenoids and health outcomes, primarily prospective cohort or population-based case-control designs, were analyzed to develop a carotenoid health index. Cutoff points across the 10th to 90th percentiles were established at 1.11, 1.47, 1.89, 2.52, and 3.07 µM. A low threshold effect appeared for all-cause mortality with protection above every cutoff except the lowest, whereas metabolic syndrome and cancer showed significant positive outcomes only above higher cutoffs. A proposed carotenoid health index categorized risk from very high (<1 µM) to very low (>4 µM), with over 95% of the US population falling into the moderate or high risk categories.

Shows an association, not proof of cause and effect.

Study type
Review of observational studies
Who was studied
Participants across 62 studies (mostly prospective cohort or case-control)
What was measured
Carotenoid health index cutoffs, all-cause mortality, metabolic syndrome, cancer

THE PAPER

A carotenoid health index based on plasma carotenoids and health outcomes.

Donaldson MS. Nutrients, 2011.

PubMed 22292108 ↗DOI 10.1056/nejm199404143301501 ↗

CancerNutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.